The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.00
Bid: 29.10
Ask: 29.70
Change: -0.90 (-3.01%)
Spread: 0.60 (2.062%)
Open: 29.00
High: 29.10
Low: 29.00
Prev. Close: 29.90
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation of share options

26 Jun 2017 07:00

RNS Number : 0676J
EKF Diagnostics Holdings PLC
26 June 2017
 

EKF Diagnostics Holdings plc

("EKF", the "Company")

 

Cancellation of share options

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that 21,614,766 share options over ordinary shares of 1 penny each (the "Ordinary Shares") granted to certain directors, PDMRs, employees and the former Chairman of the Company (the "Options") have been cancelled at the election of those holding the options (the "Optionholders") in return for the payment of a one-off cash sum.

 

Details of the cancellation of the Options are set out below:

 

PDMR

Role

Number of Options being surrendered

Cash payment (£)

Julian Baines

CEO

5,127,383

354,348

Richard Evans

COO and CFO

4,260,000

294,826

Steven Wray

Head of Sales EMEA

825,000

61,801

Gilbert Mejia

Head of Sales Americas

800,000

60,522

Martyn Lewis

Head of Marketing

800,000

61,551

Peter Coyne

Head of Operations

800,000

61,551

Ed Hitchler

General Manager, EKF USA

800,000

59,914

Steffen Borlich

General Manager, EKF Germany

800,000

61,893

Salim Hamir

Company Secretary and Head of Corporate Affairs

600,000

46,802

Colin Anderson

Deputy Finance Director

700,000

46,802

Other employees and the former Chairman

Various

6,102,383

395,331

Total

21,614,766

1,505,341

 

The cash sum to be paid to each relevant Optionholder has been calculated by reference to the mid-market share price of 21.5p, being the price at the time the offer was made to the Optionholders, with certain tax and other adjustments being applied.

 

The purpose of this cancellation is to try and simplify the Company's capital structure ahead of the previously announced intended proposed share buyback and to reduce future dilution to shareholders.

 

Following the cancellation, share options remain over a total of 1,950,000 Ordinary Shares and these are exercisable at various prices of between 20p and 37.625p and expire between 7 July 2023 and 6 April 2025.

 

As at 23 June 2017 the Company had net cash balances of approximately £3.9m after deduction of the £1.5m to be paid to the various Optionholders as set out above.

 

EKF Diagnostics Holdings plc 

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 

Richard Evans, FD & COO

N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Alex Price / Shaun Dobson / Ali Laughton-Scott

Walbrook PR Limited

Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

 

 

a)

 

Names 

Julian Baines - Chief Executive Officer

Richard Evans - Chief Operating Officer and Finance Director

Steven Wray - Head of Sales EMEA

Gilbert Mejia - Head of Sales Americas

Martyn Lewis - Head of Marketing

Peter Coyne - Head of Operations

Ed Hitchler - General Manager, EKF USA

Steffen Borlich - General Manager, EKF Germany

Salim Hamir - Company Secretary and Head of Corporate Affairs

Colin Anderson - Deputy Finance Director

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above for positions - all classified as PDMRs of EKF

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

EKF Diagnostics Holdings plc

b)

 

LEI

213800DXTF3EAUK1AR05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument 

In each case, the grant of Options over Ordinary Shares

b)

Identification code 

GB0031509804

c)

 

Nature of the transaction 

Cancellation of Options over Ordinary Shares 

d)

 

Price(s) and volume(s)

Price - n/a

Volume(s)

Julian Baines - 5,127,383 Options

Richard Evans - 4,260,000 Options

Steven Wray - 825,000 Options

Gilbert Mejia - 800,000 Options

Martyn Lewis - 800,000 Options

Peter Coyne - 800,000 Options

Ed Hitchler - 800,000 Options

Steffen Borlich - 800,000 Options

Salim Hamir -600,000 Options

Colin Anderson - 700,000 Options

 

d)

 

Aggregated information 

- Aggregated volume

- Price

 

15,512,383

N/A

e)

 

Date of the transaction 

26 June 2017

f)

 

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEASKDALFXEFF
Date   Source Headline
13th Jun 20227:00 amRNSUpdate on strong cash position
9th Jun 20227:00 amRNSLaunch of EKF Link
23rd May 20227:00 amRNSCancellation of Treasury Shares and TVR
18th May 20221:25 pmRNSResult of AGM
18th May 20227:00 amRNSAGM Statement
3rd May 20227:00 amRNSPDMR/Director Dealings & Holding(s) in Company
25th Apr 20227:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
11th Apr 20227:00 amRNSPurchase of Own Shares & Buyback Prog. Completion
8th Apr 20227:00 amRNSPurchase of Own Shares
7th Apr 20227:00 amRNSPurchase of Own Shares
6th Apr 20227:00 amRNSPurchase of Own Shares
5th Apr 20227:00 amRNSPurchase of Own Shares
4th Apr 20227:00 amRNSPurchase of Own Shares
1st Apr 20227:00 amRNSPurchase of Own Shares
31st Mar 20227:00 amRNSPurchase of Own Shares
30th Mar 20227:00 amRNSPurchase of Own Shares
29th Mar 20227:01 amRNSShare Buyback Programme
29th Mar 20227:00 amRNSFinal Results
25th Mar 20224:40 pmRNSSecond Price Monitoring Extn
25th Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20225:13 pmRNSHolding(s) in Company
7th Mar 20227:00 amRNSFurther Investment in Verici Dx plc
3rd Mar 20224:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20224:36 pmRNSPrice Monitoring Extension
3rd Mar 20227:00 amRNSNotice of Results
31st Jan 20227:00 amRNSNon-executive Directorate Change
25th Jan 20227:00 amRNSTrading update
18th Jan 20227:01 amRNSStrategic partnership agreement with Yourgene
23rd Nov 20217:00 amRNSDirectorate Change
8th Nov 20211:01 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSDividend confirmation
12th Oct 20217:00 amRNSCompletion of ADL Health Acquisition
5th Oct 20213:00 pmRNSPDMR/ PCA Dealings
5th Oct 20213:00 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSAcquisition of Advanced Diagnostic Laboratory LLC
14th Sep 20217:00 amRNSHalf-year Report
25th Aug 20217:00 amRNSNotice of Results
21st Jul 20217:00 amRNSTrading Update
16th Jun 20217:00 amRNSChange of Adviser
7th Jun 202110:10 amRNSInvestor Presentations
26th May 20215:48 pmRNSTrellus Health plc: Successful Restricted Offer
20th May 20214:31 pmRNSTrellus Health plc: Confirmation of Issue Price
19th May 202112:58 pmRNSResult of AGM
19th May 20217:01 amRNSBoard Changes and Executive Performance Bonus
19th May 20217:00 amRNSAGM Statement
18th May 20217:00 amRNSTrellus Health plc: Intention to Float - AIM
5th May 202111:14 amRNSNotice of Change of AGM Venue and Dividend Update
30th Apr 20213:52 pmRNSDirector/PDMR Shareholding
23rd Apr 20217:00 amRNSPosting of Annual Report &Accounts & Notice of AGM
22nd Apr 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.